Cote d’ Ivoire and Liberia both Launch National Immunisation Programmes for HPV (Human-Papillomavirus)

MSD (www.MSD.co.za), known as Merck & Co., Inc., (NYSE: MRK) in the United States and Canada, congratulates both Cote d’ Ivoire and Liberia on the successful launch of the National Immunisation Programme (NIP) for the Human-Papillomavirus (HPV – the main cause of cervical cancer).[1] Approximately 530 000 women are diagnosed with cervical cancer around the […]

MSD (www.MSD.co.za), known as Merck & Co., Inc., (NYSE: MRK) in the United States and Canada, congratulates both Co...

Source : http://feedproxy.google.com/~r/Appa-sourceTheAfric...